Loading...
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications
Pancreatic cancer is a highly lethal disease with a poor prognosis, and existing therapies offer only limited effectiveness. Mutation gene sequencing has shown several gene associations that may account for its carcinogenesis, revealing a promising research direction. Poly (ADP-ribose) polymerase (P...
Na minha lista:
| Udgivet i: | Mol Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7053129/ https://ncbi.nlm.nih.gov/pubmed/32122376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-020-01167-9 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|